Skip to main content
Cornerstone Pharmaceuticals, Inc. Logo
  • About
  • Research and Development
    • CPI-613® (devimistat)
    • Pipeline
  • Leadership
    • Executive Management
    • Board of Directors
    • Medical Advisors
    • Scientific Advisors
  • Clinical Trial Enrollment
  • Contact Us
  • News & Investors
    • Press Releases
    • News Coverage
    • Investor/Media Kit
    • Request Information
  • Scientific Exchange
    • Publications
    • Conference Presentations
  • Work With Us
    • Partnering
    • Careers
    • Culture
  • Compassionate Use
Clinical Trial Enrollment Contact Us
Investor/Media Kit
News & Investors
  • Press Releases
  • News Coverage
  • Investor/Media Kit
  • Request Information

Investor/Media Kit Materials

  • Executive Management Bios
  • Cornerstone Pharma CPI-613 FactSheet

Rafael Pharmaceuticals, Inc. is now
Cornerstone Pharmaceuticals, Inc.

We are who we have always been - an organization dedicated to addressing significant unmet needs with therapies for rare cancers. We've returned to our company roots with our original company name. Now, more than ever, we want our patients to know how committed we are to developing treatments for rare cancers. And that is exactly what Cornerstone represents.

Cornerstone Pharmaceuticals, Inc. Footer Logo
  • (609) 409-7050
  • info@cornerstonepharma.com
  • Cornerstone Pharmaceuticals, Inc. 1 Duncan Drive
    Cranbury, NJ 08512
Quick Links
  • Home
  • Press Releases
  • About
  • Partnering
  • Research and Development
  • Careers
  • Leadership
  • Patient Resources
Stay in Touch
  • LinkedIn
  • Facebook
  • Twitter
© 2022 Cornerstone Pharmaceuticals, Inc. All Rights Reserved
  • Terms of Service
  • Privacy Policy
  • Terms of Use